Clinical Trial: A Phase 1, Study of BMF-500 in Adults With Acute Leukemia
Study Status: Completed
Recruit Status: RECRUITING
Condition: Acute Myeloid Leukemia
Study Type: INTERVENTIONAL
Official Title: A Phase 1, Open-label, Dose-escalation, and Dose-expansion Study of BMF-500, an Oral Covalent FLT3 Inhibitor, in Adults With Acute Leukemia
Brief Summary:
A Phase 1 first-in-human dose-escalation and dose-expansion study of BMF-500, an oral FLT3 inhibitor, in adult patients with acute leukemia.
Read more